Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00493454
Status:
TERMINATED
Last Update Posted:
2013-05-31
First Post:
2007-06-27
Brief Title:
Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20 Indolent Lymphomas
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-27
First Submit QC Date:
June 27 2007
Study First Post Date:
2007-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-05-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-30
Last Update Post Date:
2013-05-31
Last Update Post Date Type:
ESTIMATED